We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Psychedelics – News and Features

Two white mushrooms.

Psilocybin Shows Promise for Treatment-Resistant Depression – But Is It Safe?

Commonly referred to as “magic mushrooms,” psilocybin is a promising alternative treatment for people with medication-resistant depression and anxiety.
A person holding their hand up to a window while it rains outside.

Ketamine Reduces Depression After Childbirth, Study Finds

A single low dose of esketamine – the active form of the anesthetic drug, ketamine – can reduce depressive episodes when given immediately after childbirth, a new study has found.
A needle with a drop of liquid at the end.

Tiam1’s Role in Morphine Tolerance Mechanism Identified

New research has shown how blocking the activity of the Tiam1 enzyme in certain spinal neurons could reduce morphine tolerance and prolong the usefulness of morphine for pain relief.
3D model of a human brain

Distinct Brain Mechanisms for Emotion Generation and Regulation Identified

Researchers have identified multiple brain regions that are unique to regulating emotions. The study is among the first of its kind to separate activity relating to emotion generation from emotion regulation in the human brain.
Representation of psychedelic hallucination.

What Does 2024 Have in Store for Psychedelic Science?

The hype and promise around psychedelic drug trials have accelerated legislation to liberalize access to these compounds. In this article, we delve into the pivotal events in psychedelic science that researchers in the field predict will shape the year 2024.
A syringe on a yellow background.

Study Uncovers How Ketamine Works Both Rapidly and Long-Term

New treatments for depression are needed that act rapidly and also have sustained effects. Ketamine could be the answer.
A person looks down from space towards the Earth.

The Next Chapter of Science

Join us as we explore how innovation, ethics and even aesthetics look set to influence the landscape of life science research, creating new possibilities for treating human diseases, feeding our growing population and nurturing the scientists of the future.
An abstract image of the universe within the mind.

What Happens in the Human Brain After Taking DMT?

How, exactly, DMT alters brain function to produce positive effects observed in clinical trials is not yet clear, though a study from scientists at Imperial College London has shed some light.
An artist's drawing of the iboga plant's flower.

African Psychedelic Ibogaine Reduces Veterans’ Brain Injury Symptoms in Small Trial

A traditional African psychedelic drug reduced symptoms of veterans’ brain injury in a small clinical study published in Nature Medicine.

Drugs in different shapes, sizes and colors.

Neuropsychological Effects of Rapid-Acting Antidepressants May Explain Their Benefits

New research has identified the neuropsychological effects of rapid-acting antidepressants, like ketamine and psilocybin, that underpin their effectiveness.